129 related articles for article (PubMed ID: 36385962)
1. SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma.
Luo N; Tan Y; Deng H; Wu W; Mei L; Huang X; Qin Y; Zhu H; Liu C
J Oncol; 2022; 2022():5821545. PubMed ID: 36385962
[TBL] [Abstract][Full Text] [Related]
2. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
3. SRPX2 promotes cancer cell proliferation and migration of papillary thyroid cancer.
Guo H; Liu R; Wu J; Li S; Yao W; Xu J; Zheng C; Lu Y; Zhang H
Clin Exp Med; 2023 Dec; 23(8):4825-4834. PubMed ID: 37306872
[TBL] [Abstract][Full Text] [Related]
4. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
Lin X; Chang W; Wang Y; Tian M; Yu Z
Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
[TBL] [Abstract][Full Text] [Related]
5. SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.
Tanaka K; Arao T; Maegawa M; Matsumoto K; Kaneda H; Kudo K; Fujita Y; Yokote H; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
Int J Cancer; 2009 Mar; 124(5):1072-80. PubMed ID: 19065654
[TBL] [Abstract][Full Text] [Related]
6. SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.
Gao Z; Zhang J; Bi M; Han X; Han Z; Wang H; Ou Y
Int J Clin Exp Pathol; 2015; 8(5):4791-8. PubMed ID: 26191169
[TBL] [Abstract][Full Text] [Related]
7. Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer.
Shibata M; Inaishi T; Ichikawa T; Shimizu D; Soeda I; Takano Y; Takeuchi D; Tsunoda N; Kikumori T
Surg Today; 2021 Oct; 51(10):1703-1712. PubMed ID: 33733290
[TBL] [Abstract][Full Text] [Related]
8. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
9. SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway.
Wu Z; Wang C; Chen Y; Sun Z; Yan W
Onco Targets Ther; 2020; 13():1737-1749. PubMed ID: 32161469
[TBL] [Abstract][Full Text] [Related]
10. CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer.
Zhao W; Chen S; Hou X; Chen G; Zhao Y
Cell Physiol Biochem; 2018; 45(4):1590-1602. PubMed ID: 29486482
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
[TBL] [Abstract][Full Text] [Related]
12. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
[TBL] [Abstract][Full Text] [Related]
13. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
14. Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways.
Liu K; Fan J; Wu J
Drug Discov Ther; 2017; 11(4):212-217. PubMed ID: 28867754
[TBL] [Abstract][Full Text] [Related]
15. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
17. circSSU72 Promotes Cell Proliferation, Migration and Invasion of Papillary Thyroid Carcinoma Cells by Targeting miR-451a/S1PR2 Axis.
Zhang Z; Xia F; Yao L; Jiang B; Li X
Front Cell Dev Biol; 2022; 10():817028. PubMed ID: 35372340
[No Abstract] [Full Text] [Related]
18. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
20. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]